- Home
- MRAM vs ANVS Comparison
MRAM vs ANVS Comparison
Compare MRAM & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRAM
- ANVS
- Stock Information
- Founded
- MRAM 2008
- ANVS 2008
- Country
- MRAM United States
- ANVS United States
- Employees
- MRAM N/A
- ANVS N/A
- Industry
- MRAM Semiconductors
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- MRAM Technology
- ANVS Health Care
- Exchange
- MRAM Nasdaq
- ANVS Nasdaq
- Market Cap
- MRAM 150.5M
- ANVS 48.3M
- IPO Year
- MRAM 2016
- ANVS 2020
- Fundamental
- Price
- MRAM $8.07
- ANVS $2.34
- Analyst Decision
- MRAM Strong Buy
- ANVS Strong Buy
- Analyst Count
- MRAM 1
- ANVS 4
- Target Price
- MRAM $8.00
- ANVS $17.33
- AVG Volume (30 Days)
- MRAM 111.0K
- ANVS 198.0K
- Earning Date
- MRAM 10-29-2025
- ANVS 11-07-2025
- Dividend Yield
- MRAM N/A
- ANVS N/A
- EPS Growth
- MRAM 2.00
- ANVS N/A
- EPS
- MRAM 0.07
- ANVS N/A
- Revenue
- MRAM $51,675,000.00
- ANVS N/A
- Revenue This Year
- MRAM $10.80
- ANVS N/A
- Revenue Next Year
- MRAM $13.42
- ANVS N/A
- P/E Ratio
- MRAM $105.93
- ANVS N/A
- Revenue Growth
- MRAM N/A
- ANVS N/A
- 52 Week Low
- MRAM $4.34
- ANVS $1.11
- 52 Week High
- MRAM $8.10
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- MRAM 80.50
- ANVS 45.96
- Support Level
- MRAM $6.20
- ANVS $2.26
- Resistance Level
- MRAM $6.99
- ANVS $2.51
- Average True Range (ATR)
- MRAM 0.31
- ANVS 0.11
- MACD
- MRAM 0.17
- ANVS 0.01
- Stochastic Oscillator
- MRAM 99.49
- ANVS 46.77
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.